Dana-Farber Cancer Institute
G

Updates on AL Amyloidosis Treatment: What’s New in 2024

By Dana-Farber Cancer Institute FEATURING Giada Bianchi
By Dana-Farber Cancer Institute FEATURING Giada Bianchi
0 views
July 2, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Recommended

AUTOPLAY
20:17
Indy Hematology Review

Managing Amyloidosis in 2024: Diagnosis and Treatment

Feat. M. Gertz
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
13:43
Houston Methodist Hospital

Lung Involvement in Amyloidosis

Feat. H. Huang
27:11
MyCancerHaven

POEMS Syndrome Management

Feat. R. Vij, D. Dingli
04:15
Indy Hematology Review

Indy Hematology Review 2023: Plasma Cell Neoplasms and Amyloidosis U…

Feat. M. Gertz
13:22
SOHO Brazil 2024

Managing Infectious Complications With Bispecific and CAR-T Therapy …

Feat. N. S. Raje
23:34
MyCancerHaven

Experts Discuss the Diagnosis and Management of High-Risk Multiple M…

Feat. R. Vij, M. Alsina
10:25
Morie Gertz

"You Have AL-Amyloidosis": Counseling Newly Diagnosed Pati…

22:02
Rush University Medical Center

High-Risk Myeloma: Updates in Defining and Managing

Feat. J. Zonder
19:39
Yale Cancer Center

AL Amyloidosis Treatment Updates

Feat. T. Parker
25:52
Rush University Medical Center

CAR-T vs. Bispecific Antibodies in R/R MM: Insights and Future Direc…

Feat. A. Suvannasankha
21:03
Yale Cancer Center

Renal AL Amyloid

Feat. R. Luciano
10:23
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "iStopMM Study - Revised Definition of Free …

Feat. T. Einarsson Long
27:05
American Society of Nuclear Cardiology

Interpreting a PYP Study for TTR Cardiac Amyloid

Feat. P. Soman, M. Harinstein, S. Divakaran
27:26
Houston Methodist Hospital

FDA Perspective on New Therapies for Amyloidosis

Feat. R. Adigun
18:06
MyCancerHaven

Experts Discuss Novel Antibodies for the Management of Amyloidosis

Feat. R. Vij, S. Lentzsch
19:10
Houston Methodist Hospital

Amyloidosis: Pathophysiology

Feat. S. Ganguly
12:03
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Daratumumab Monotherapy in Newly Diagnosed …

Feat. E. Kastritis
30:34
Houston Methodist Hospital

Current Treatment Options for AL Amyloidosis

Feat. K. Baker
26:58
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

2024 Updates on Myeloma Precursor Diseases and AL Amyloidosis

Feat. S. Susanibar-Adaniya